The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Cynata CEO Dr Kilian Kelly presented on Cynata’s Cymerus technology and provided an update on the Company’s robust clinical pipeline.